Although modern medical science has improved disease management through innovative medicine and technology (e.g., insulin for diabetes control and diuretic and beta-blocker for heart failure), medical science alone is unlikely to reduce costly ACSC hospitalizations or ED visits, especially for socially vulnerable individuals. The gene discussed is INS; the disease is heart failure.